Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 5
1989 5
1990 5
1991 7
1992 2
1993 8
1994 3
1995 3
1996 13
1997 11
1998 26
1999 24
2000 25
2001 24
2002 29
2003 37
2004 25
2005 34
2006 35
2007 37
2008 32
2009 42
2010 50
2011 39
2012 34
2013 40
2014 70
2015 78
2016 109
2017 103
2018 104
2019 83
2020 131
2021 131
Text availability
Article attribute
Article type
Publication date

Search Results

1,286 results
Results by year
Filters applied: . Clear all
Page 1
MDS clinical diagnostic criteria for Parkinson's disease.
Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G. Postuma RB, et al. Mov Disord. 2015 Oct;30(12):1591-601. doi: 10.1002/mds.26424. Mov Disord. 2015. PMID: 26474316 Review.
This document presents the Movement Disorder Society Clinical Diagnostic Criteria for Parkinson's disease (PD). The Movement Disorder Society PD Criteria are intended for use in clinical research but also may be used to guide clinical diagnosis. ...Similar to …
This document presents the Movement Disorder Society Clinical Diagnostic Criteria for Parkinson's disease (PD). The Mov …
New evidence on the management of Lewy body dementia.
Taylor JP, McKeith IG, Burn DJ, Boeve BF, Weintraub D, Bamford C, Allan LM, Thomas AJ, O'Brien JT. Taylor JP, et al. Lancet Neurol. 2020 Feb;19(2):157-169. doi: 10.1016/S1474-4422(19)30153-X. Epub 2019 Sep 10. Lancet Neurol. 2020. PMID: 31519472 Free PMC article. Review.
Dementia with Lewy bodies and Parkinson's disease dementia, jointly known as Lewy body dementia, are common neurodegenerative conditions. ...Furthermore, consensus opinion from experts supports the application of treatments for related conditions, such as …
Dementia with Lewy bodies and Parkinson's disease dementia, jointly known as Lewy body dementia, are common neurodegene …
Neuropathology of Parkinson disease.
Dickson DW. Dickson DW. Parkinsonism Relat Disord. 2018 Jan;46 Suppl 1(Suppl 1):S30-S33. doi: 10.1016/j.parkreldis.2017.07.033. Epub 2017 Aug 1. Parkinsonism Relat Disord. 2018. PMID: 28780180 Free PMC article. Review.
INTRODUCTION: Parkinson's disease (PD) is characterized by bradykinesia, rigidity, postural instability and tremor. ...Some patients with PD are found at autopsy to have other pathologic processes, such as multiple system atrophy, progressive supranuclear pal …
INTRODUCTION: Parkinson's disease (PD) is characterized by bradykinesia, rigidity, postural instability and tremor. ... …
Autophagy in Parkinson's Disease.
Hou X, Watzlawik JO, Fiesel FC, Springer W. Hou X, et al. J Mol Biol. 2020 Apr 3;432(8):2651-2672. doi: 10.1016/j.jmb.2020.01.037. Epub 2020 Feb 13. J Mol Biol. 2020. PMID: 32061929 Free PMC article. Review.
Impaired protein homeostasis and accumulation of damaged or abnormally modified protein are common disease mechanisms in many neurodegenerative disorders, including Parkinson's disease (PD). ...
Impaired protein homeostasis and accumulation of damaged or abnormally modified protein are common disease mechanisms in many neurode …
Discriminating alpha-synuclein strains in Parkinson's disease and multiple system atrophy.
Shahnawaz M, Mukherjee A, Pritzkow S, Mendez N, Rabadia P, Liu X, Hu B, Schmeichel A, Singer W, Wu G, Tsai AL, Shirani H, Nilsson KPR, Low PA, Soto C. Shahnawaz M, et al. Nature. 2020 Feb;578(7794):273-277. doi: 10.1038/s41586-020-1984-7. Epub 2020 Feb 5. Nature. 2020. PMID: 32025029 Free PMC article.
Synucleinopathies are neurodegenerative diseases that are associated with the misfolding and aggregation of alpha-synuclein, including Parkinson's disease, dementia with Lewy bodies and multiple system atrophy(1). Clinically, it is challenging to differentiat …
Synucleinopathies are neurodegenerative diseases that are associated with the misfolding and aggregation of alpha-synuclein, including Pa
Locus coeruleus.
Benarroch EE. Benarroch EE. Cell Tissue Res. 2018 Jul;373(1):221-232. doi: 10.1007/s00441-017-2649-1. Epub 2017 Jul 7. Cell Tissue Res. 2018. PMID: 28687925 Review.
The LC is severely affected in neurodegenerative disorders including Parkinson disease (PD). Involvement of the noradrenergic neurons of the LC precedes that of dopaminergic neurons of the substantia nigra pars compacta and has been increasingly recognized as a pote …
The LC is severely affected in neurodegenerative disorders including Parkinson disease (PD). Involvement of the noradrenergic …
MDS research criteria for prodromal Parkinson's disease.
Berg D, Postuma RB, Adler CH, Bloem BR, Chan P, Dubois B, Gasser T, Goetz CG, Halliday G, Joseph L, Lang AE, Liepelt-Scarfone I, Litvan I, Marek K, Obeso J, Oertel W, Olanow CW, Poewe W, Stern M, Deuschl G. Berg D, et al. Mov Disord. 2015 Oct;30(12):1600-11. doi: 10.1002/mds.26431. Mov Disord. 2015. PMID: 26474317 Review.
The criteria are based upon the likelihood of prodromal disease being present with probable prodromal PD defined as 80% certainty. Certainty estimates rely upon calculation of an individual's risk of having prodromal PD, using a Bayesian naive classifier. ...
The criteria are based upon the likelihood of prodromal disease being present with probable prodromal PD defined as 80% certainty. Ce …
Parkinson disease and the gut: new insights into pathogenesis and clinical relevance.
Travagli RA, Browning KN, Camilleri M. Travagli RA, et al. Nat Rev Gastroenterol Hepatol. 2020 Nov;17(11):673-685. doi: 10.1038/s41575-020-0339-z. Epub 2020 Jul 31. Nat Rev Gastroenterol Hepatol. 2020. PMID: 32737460 Review.
The classic view portrays Parkinson disease (PD) as a motor disorder resulting from loss of substantia nigra pars compacta dopaminergic neurons. ...The histological hallmark of PD - misfolded alpha-synuclein aggregates that form Lewy bodies and neurites - is detecte …
The classic view portrays Parkinson disease (PD) as a motor disorder resulting from loss of substantia nigra pars compacta dop …
Biomarkers in Parkinson's disease: Advances and strategies.
Delenclos M, Jones DR, McLean PJ, Uitti RJ. Delenclos M, et al. Parkinsonism Relat Disord. 2016 Jan;22 Suppl 1(Suppl 1):S106-10. doi: 10.1016/j.parkreldis.2015.09.048. Epub 2015 Sep 30. Parkinsonism Relat Disord. 2016. PMID: 26439946 Free PMC article. Review.
Parkinson's disease (PD) is a neurodegenerative disorder characterized by progressive motor disturbances and affects more than 1% of the worldwide population. ...
Parkinson's disease (PD) is a neurodegenerative disorder characterized by progressive motor disturbances and affects mo
REM Sleep Behavior Disorder in Parkinson's Disease and Other Synucleinopathies.
St Louis EK, Boeve AR, Boeve BF. St Louis EK, et al. Mov Disord. 2017 May;32(5):645-658. doi: 10.1002/mds.27018. Mov Disord. 2017. PMID: 28513079 Review.
Rapid eye movement sleep behavior disorder may be idiopathic or symptomatic and in both settings is highly associated with synucleinopathy neurodegeneration, especially Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, and pure autonomi …
Rapid eye movement sleep behavior disorder may be idiopathic or symptomatic and in both settings is highly associated with synucleinopathy n …
1,286 results